OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 140 filers reported holding OPHTHOTECH CORP in Q2 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $330,000 | -46.1% | 121,048 | -45.8% | 0.02% | -50.0% |
Q1 2018 | $612,000 | -34.1% | 223,249 | +16.2% | 0.03% | -41.8% |
Q4 2016 | $928,000 | +19.0% | 192,168 | +1035.9% | 0.06% | +31.0% |
Q3 2016 | $780,000 | +38.1% | 16,918 | +26.5% | 0.04% | +16.7% |
Q1 2016 | $565,000 | -57.5% | 13,371 | -20.9% | 0.04% | -44.6% |
Q4 2015 | $1,328,000 | +131.4% | 16,908 | +19.4% | 0.06% | +132.1% |
Q3 2015 | $574,000 | +52.7% | 14,165 | +96.1% | 0.03% | +100.0% |
Q2 2015 | $376,000 | -74.9% | 7,223 | -77.6% | 0.01% | -76.7% |
Q1 2015 | $1,498,000 | +587.2% | 32,200 | +475.0% | 0.06% | +445.5% |
Q3 2014 | $218,000 | – | 5,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |